174 related articles for article (PubMed ID: 14524095)
1. [Lisinopril in the treatment of patients with chronic cor pulmonale].
Verbitskiĭ ON; Butorov IV; Purkh TIu; Fadi FM; Paraska VI
Probl Tuberk Bolezn Legk; 2003; (8):22-5. PubMed ID: 14524095
[No Abstract] [Full Text] [Related]
2. [Efficiency of ramipril treatment in patients with chronic obstructive bronchitis complicated by chronic cor pulmonale].
Butorov IV; Vatulin VN; Bodrug NI; Fuduleĭ RF; Matkovskiĭ SK; Butorova VG
Probl Tuberk; 1999; (6):42-4. PubMed ID: 10715959
[TBL] [Abstract][Full Text] [Related]
3. [Effectiveness of dirotone in the treatment of chronic cor pulmonale].
Verbitskiĭ ON; Butorov IV
Probl Tuberk; 2001; (5):27-9. PubMed ID: 11588955
[No Abstract] [Full Text] [Related]
4. [Effectiveness of enalapril in chronic cor pulmonale].
Vasilenko GP; Vereshchagina GN; Dolganova DN; Morzhueva NM; Popova SS
Klin Med (Mosk); 1999; 77(10):45-7. PubMed ID: 10635655
[TBL] [Abstract][Full Text] [Related]
5. [The use of capoten in the treatment of chronic cor pulmonale in elderly patients].
Kalinovskaia EG; Galaka VV; Dzhemaĭlo VI; Shmidt AD; Orlov PA; Chebotarev ND; Sarkisova EA
Vestn Akad Med Nauk SSSR; 1990; (3):52-4. PubMed ID: 2191513
[TBL] [Abstract][Full Text] [Related]
6. [Long-term dirotone treatment of patients with chronic obstructive bronchitis complicated by cor pulmonale].
Korneĭchuk NN; Butorov IV; Berbitskiĭ ON; Butorov SI; Ridlovskiĭ AIu
Klin Med (Mosk); 2002; 80(5):53-7. PubMed ID: 12087890
[TBL] [Abstract][Full Text] [Related]
7. Renal outcomes in high-risk hypertensive patients treated with an angiotensin-converting enzyme inhibitor or a calcium channel blocker vs a diuretic: a report from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).
Rahman M; Pressel S; Davis BR; Nwachuku C; Wright JT; Whelton PK; Barzilay J; Batuman V; Eckfeldt JH; Farber M; Henriquez M; Kopyt N; Louis GT; Saklayen M; Stanford C; Walworth C; Ward H; Wiegmann T
Arch Intern Med; 2005 Apr; 165(8):936-46. PubMed ID: 15851647
[TBL] [Abstract][Full Text] [Related]
8. [Characteristics of the coronary circulation in cor pulmonale].
Medvedev ES; Markova MA; Podolian LM
Ter Arkh; 1972 Dec; 44(12):94-6. PubMed ID: 4666361
[No Abstract] [Full Text] [Related]
9. Hydrochlorothiazide increases plasma or tissue angiotensin-converting enzyme-inhibitor drug levels in rats with myocardial infarction: differential effects on lisinopril and zofenopril.
Westendorp B; Schoemaker RG; van Gilst WH; van Veldhuisen DJ; Buikema H
Eur J Pharmacol; 2005 Dec; 527(1-3):141-9. PubMed ID: 16310764
[TBL] [Abstract][Full Text] [Related]
10. [Treatment of chronic cor pulmonale].
Bugaĭ LV
Vrach Delo; 1981 Feb; (2):62-4. PubMed ID: 7222614
[No Abstract] [Full Text] [Related]
11. [Treatment and outpatient observation of patients with chronic cor pulmonale].
Butorov IV
Sov Med; 1988; (10):90-2. PubMed ID: 3242102
[No Abstract] [Full Text] [Related]
12. [Effect of cardiac glycosides on the hemodynamics of pulmonary circulation in patients with chronic cor pulmonale].
Gavrisiuk VK; Diachenko AP; Morskaia ND; Iachnik AI
Probl Tuberk; 1988; (2):45-7. PubMed ID: 3375218
[No Abstract] [Full Text] [Related]
13. [Effect of ganglioblockaders on blood circulation and external respiration in chronic cor pulmonale].
Lapteva IM
Vrach Delo; 1980 Jan; (1):50-3. PubMed ID: 6103597
[No Abstract] [Full Text] [Related]
14. [Effect of strophanthin on the functional state of the myocardium and external respiratory indices in chronic cor pulmonale].
Berezhnitskiĭ MN; Vakaliuk PM; Bygar PV
Vrach Delo; 1980 Jan; (1):44-7. PubMed ID: 7376581
[No Abstract] [Full Text] [Related]
15. Are angiotensin-converting enzyme (ACE) inhibitors effective in preventing migraine in nonhypertensive patients?
Montgomery L
J Fam Pract; 2001 Apr; 50(4):299. PubMed ID: 11300977
[No Abstract] [Full Text] [Related]
16. Myocardial function in chronic pulmonary diseases. The role of the coronary arteries in chronic cor pulmonale.
Baroldi G
Bull Physiopathol Respir (Nancy); 1972; 8(6):1406-7. PubMed ID: 4267071
[No Abstract] [Full Text] [Related]
17. A comparison of the tolerability of the direct renin inhibitor aliskiren and lisinopril in patients with severe hypertension.
Strasser RH; Puig JG; Farsang C; Croket M; Li J; van Ingen H
J Hum Hypertens; 2007 Oct; 21(10):780-7. PubMed ID: 17541390
[TBL] [Abstract][Full Text] [Related]
18. Causes of death in patients with acute myocardial infarction treated with angiotensin-converting enzyme inhibitors: findings from the Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto (GISSI)-3 trial.
Pedrazzini G; Santoro E; Latini R; Fromm L; Franzosi MG; Mocetti T; Staszewsky L; Barlera S; Tognoni G; Maggioni AP;
Am Heart J; 2008 Feb; 155(2):388-94. PubMed ID: 18215613
[TBL] [Abstract][Full Text] [Related]
19. Angiotensin converting enzyme inhibitor improves nephrotic syndrome associated with cyanotic congenital heart disease.
Watanabe Y; Fukuzawa Y; Inaguma D
Clin Nephrol; 1996 May; 45(5):362-3. PubMed ID: 8738675
[No Abstract] [Full Text] [Related]
20. [Lisinopril-induced changes in antioxidant defense in patients with acute coronary syndrome and concomitant diabetes mellitus type 2].
Kratnov AE; Popov SA; Kratnov AA; Dem'iankova IuO
Ter Arkh; 2005; 77(12):14-8. PubMed ID: 16514812
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
